Ocugen, Inc. (OCGN)
1.37
-0.04
(-2.84%)
USD |
NASDAQ |
Aug 27, 16:00
1.37
0.00 (0.00%)
After-Hours: 20:00
Ocugen Debt to Equity Ratio : -5.314 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.314 |
| March 31, 2026 | 5.736 |
| December 31, 2025 | -2.724 |
| September 30, 2025 | 9.330 |
| June 30, 2025 | 10.75 |
| March 31, 2025 | 2.000 |
| December 31, 2024 | 1.097 |
| September 30, 2024 | 0.1669 |
| June 30, 2024 | 0.4056 |
| March 31, 2024 | 0.2258 |
| December 31, 2023 | 0.1711 |
| September 30, 2023 | 0.1109 |
| June 30, 2023 | 0.0935 |
| March 31, 2023 | 0.0828 |
| December 31, 2022 | 0.0862 |
| September 30, 2022 | 0.0679 |
| June 30, 2022 | 0.0522 |
| March 31, 2022 | 0.0241 |
| December 31, 2021 | 0.0345 |
| September 30, 2021 | 0.0294 |
| June 30, 2021 | 0.0272 |
| March 31, 2021 | 0.0778 |
| December 31, 2020 | 0.1156 |
| September 30, 2020 | 0.2332 |
| June 30, 2020 | 0.4334 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.2569 |
| December 31, 2019 | 0.1277 |
| September 30, 2019 | -0.1123 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | -1.453 |
| December 31, 2018 | -0.6688 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | -0.0022 |
| December 31, 2017 | -0.0158 |
| September 30, 2017 | -0.0673 |
| June 30, 2017 | 0.5831 |
| March 31, 2017 | 0.0882 |
| December 31, 2016 | 0.0561 |
| September 30, 2016 | 0.2247 |
| June 30, 2016 | 0.0817 |
| March 31, 2016 | 0.0582 |
| December 31, 2015 | 0.0477 |
| September 30, 2015 | 0.0412 |
| June 30, 2015 | 0.0373 |
| March 31, 2015 | 0.0339 |
| December 31, 2014 | 0.0323 |
| September 30, 2014 | -0.3327 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| CytomX Therapeutics, Inc. | 0.0189 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Biogen, Inc. | 0.4433 |
| Gilead Sciences, Inc. | 2.219 |
| MannKind Corp. | -6.494 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 124.21M |
| Total Liabilities (Quarterly) | 140.76M |
| Shareholders Equity (Quarterly) | -16.56M |
| Current Ratio | 0.8019 |
| Net Debt Paydown Yield | -2.17% |